Innospec Inc. (LON:0JAX)
London flag London · Delayed Price · Currency is GBP · Price in USD
72.00
-4.88 (-6.35%)
At close: Mar 6, 2026

Innospec Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,7781,8451,9491,9641,483
Revenue Growth (YoY)
-3.65%-5.31%-0.76%32.38%24.33%
Cost of Revenue
1,2861,3031,3581,3771,049
Gross Profit
492.4542.9591.1586.7434.9
Selling, General & Admin
285.1305.3380.5360.7267.2
Research & Development
5156.54938.737.4
Other Operating Expenses
59-3.2--1.8
Operating Income
129.5177.9161.6187.3132.1
Interest Expense
9.29.32.3-1.1-1.5
Other Non-Operating Income (Expense)
-0.6-14610.5-1.63.8
Total Non-Operating Income (Expense)
8.6-136.712.8-2.72.3
Pretax Income
138.141.2174.4184.6134.4
Provision for Income Taxes
21.55.635.351.641.3
Net Income
116.635.6139.113393.1
Net Income to Common
116.635.6139.113393.1
Net Income Growth
227.53%-74.41%4.59%42.86%224.39%
Shares Outstanding (Basic)
2525252525
Shares Outstanding (Diluted)
2525252525
Shares Change (YoY)
-0.50%0.39%0.16%0.52%0.30%
EPS (Basic)
4.691.435.605.373.78
EPS (Diluted)
4.671.425.565.323.75
EPS Growth
228.87%-74.46%4.51%41.87%223.28%
Free Cash Flow
88143.1145.242.154.1
Free Cash Flow Growth
-38.51%-1.45%244.89%-22.18%-53.44%
Free Cash Flow Per Share
3.525.705.801.692.18
Dividends Per Share
1.7101.5501.4101.2801.160
Dividend Growth
10.32%9.93%10.16%10.35%11.54%
Gross Margin
27.69%29.42%30.33%29.88%29.32%
Operating Margin
7.28%9.64%8.29%9.54%8.91%
Profit Margin
6.56%1.93%7.14%6.77%6.28%
FCF Margin
4.95%7.75%7.45%2.14%3.65%
EBITDA
173.1221.4200.9227.4174.8
EBITDA Margin
9.74%12.00%10.31%11.58%11.78%
EBIT
129.5177.9161.6187.3132.1
EBIT Margin
7.28%9.64%8.29%9.54%8.91%
Effective Tax Rate
15.57%13.59%20.24%27.95%30.73%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.